R Malinverni

1.7k total citations · 1 hit paper
35 papers, 1.2k citations indexed

About

R Malinverni is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, R Malinverni has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 8 papers in Infectious Diseases and 4 papers in Hepatology. Recurrent topics in R Malinverni's work include Infective Endocarditis Diagnosis and Management (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). R Malinverni is often cited by papers focused on Infective Endocarditis Diagnosis and Management (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). R Malinverni collaborates with scholars based in Switzerland, United States and Italy. R Malinverni's co-authors include P Francioli, Bernard Hirschel, Pietro Vernazza, Markus Flepp, Manuel Battegay, Martin Rickenbach, Philippe Sudre, Matthias Egger, Jacques Billé and M. P. Glauser and has published in prestigious journals such as Circulation, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

R Malinverni

32 papers receiving 1.1k citations

Hit Papers

Impact of new antiretroviral combination therapies in HIV... 1997 2026 2006 2016 1997 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
    1997 502 citations Matthias Egger, Bernard Hirschel et al. BMJ profile →

Peers

R Malinverni
Catherine F. Decker United States
Ian Cropley United Kingdom
Mary Bavaro United States
Bruce L. Gilliam United States
Melvyn Smith United Kingdom
Hung‐Chin Tsai Taiwan
Michael L. Landrum United States
P. Weinbreck France
J Modaï France
Robert Ward United States
Catherine F. Decker United States
R Malinverni
Citations per year, relative to R Malinverni R Malinverni (= 1×) peers Catherine F. Decker

Countries citing papers authored by R Malinverni

Since Specialization
Citations

This map shows the geographic impact of R Malinverni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Malinverni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Malinverni more than expected).

Fields of papers citing papers by R Malinverni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Malinverni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Malinverni. The network helps show where R Malinverni may publish in the future.

Co-authorship network of co-authors of R Malinverni

This figure shows the co-authorship network connecting the top 25 collaborators of R Malinverni. A scholar is included among the top collaborators of R Malinverni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Malinverni. R Malinverni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bibert, Stéphanie, Zoltán Kutalik, Kazuo Morikawa, et al.. (2011). 1357 A LARGE-SCALE GENETIC VALIDATION STUDY COUPLED WITH IN-VITRO ANALYSES REVEAL A ROLE OF VITAMIN D-SIGNALING IN THE PATHOGENESIS AND TREATMENT OF CHRONIC HEPATITIS C. Journal of Hepatology. 54. S537–S537. 1 indexed citations
3.
Giulieri, Stefano, Daniel Genné, R Malinverni, et al.. (2011). Outbreak of Mycobacterium haemophilum Infections after Permanent Makeup of the Eyebrows. Clinical Infectious Diseases. 52(4). 488–491. 45 indexed citations
4.
Müllhaupt, Beat, Darius Moradpour, Francesco Negro, et al.. (2010). Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C. Journal of Viral Hepatitis. 17(12). 845–850. 11 indexed citations
5.
Genné, Daniel, Jan Borovicka, Andreas Cerny, et al.. (2010). Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study. Swiss Medical Weekly. 140(2930). w13055–w13055. 4 indexed citations
6.
Genini, Sem, et al.. (2008). Diagnostic Markers for Diseases: SELDI-TOF Profiling of Pig Sera for PRRS. PubMed. 132. 399–403. 2 indexed citations
7.
Moret, Jacqueline, et al.. (2008). Tick bites in a Lyme borreliosis highly endemic area in Switzerland. International Journal of Medical Microbiology. 299(2). 155–160. 31 indexed citations
8.
Malinverni, R, et al.. (2008). Bactériurie asymptomatique chez l’adulte : prise en charge différenciée. Revue Médicale Suisse. 4(179). 2452–2456.
9.
10.
Egger, Matthias, Bernard Hirschel, P Francioli, et al.. (1997). Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ. 315(7117). 1194–1199. 502 indexed citations breakdown →
11.
Filho, Martino Martinelli, Heinz J. Schaad, R Streuli, et al.. (1997). Familial Transmission of a Serious Disease–Producing Group A Streptococcus Clone: Case Reports and Review. Clinical Infectious Diseases. 24(6). 1118–1121. 50 indexed citations
12.
Malinverni, R, C.‐C. Jay Kuo, Lee Ann Campbell, & J. Thomas Grayston. (1995). Reactivation of Chlamydia pneumoniae Lung Infection in Mice by Cortisone. The Journal of Infectious Diseases. 172(2). 593–594. 67 indexed citations
13.
Malinverni, R, et al.. (1995). Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis. Antimicrobial Agents and Chemotherapy. 39(1). 45–49. 36 indexed citations
14.
Furrer, H & R Malinverni. (1994). [Urinary tract infections in adults: old and current aspects].. PubMed. 51(12). 842–52. 1 indexed citations
15.
Telenti, Amalio, Dominik E. Uehlinger, Federica Marchesi, et al.. (1993). Epstein-Barr virus infection in HIV-positive patients. European Journal of Clinical Microbiology & Infectious Diseases. 12(8). 601–609. 32 indexed citations
16.
Entenza, José M., et al.. (1992). Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats. Antimicrobial Agents and Chemotherapy. 36(6). 1256–1262. 12 indexed citations
17.
Malinverni, R. (1990). [DF-2, a "new" gram-negative bacterium].. PubMed. 120(20). 745–9. 2 indexed citations
18.
Malinverni, R & M. P. Glauser. (1988). Comparative Studies of Fluoroquinolones in the Treatment of Urinary Tract Infections. Clinical Infectious Diseases. 10(Supplement_1). S153–S163. 42 indexed citations
19.
Moreillon, Philippe, C. Daniel Overholser, R Malinverni, Jacques Billé, & M. P. Glauser. (1988). Predictors of Endocarditis in Isolates from Cultures of Blood Following Dental Extractions in Rats with Periodontal Disease. The Journal of Infectious Diseases. 157(5). 990–995. 37 indexed citations
20.
Perronne, C., R Malinverni, & M. P. Glauser. (1987). Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination. Antimicrobial Agents and Chemotherapy. 31(4). 539–543. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine F. Decker Breakdown of academic impact, for papers by Ian Cropley Breakdown of academic impact, for papers by Mary Bavaro Breakdown of academic impact, for papers by Bruce L. Gilliam Breakdown of academic impact, for papers by Melvyn Smith Breakdown of academic impact, for papers by Hung‐Chin Tsai Breakdown of academic impact, for papers by Michael L. Landrum Breakdown of academic impact, for papers by P. Weinbreck Breakdown of academic impact, for papers by J Modaï Breakdown of academic impact, for papers by Robert Ward
Rankless by CCL
2026